Atrial fibrillation (AF) is the most common cardiac arrhythmia facing physicians, afflicting
13% of men and 11% of women over 85 years of age. Epidemiological studies estimate that …

Although atrial fibrillation (AF) is the most common sustained arrhythmia seen during daily
cardiovascular physician practice, its management remained a challenge for cardiology …

Despite recent advances in our understanding of the mechanism of atrial fibrillation (AF),
effective treatment remains difficult in many patients. Pharmacotherapy remains the …

In the light of the progressively increasing prevalence of atrial fibrillation (AF), medical
awareness of the need to develop improved therapeutic approaches for the arrhythmia has …

Atrial fibrillation (AF) is a highly prevalent arrhythmia and responsible for significant
morbidity, mortality and health care cost. The prevalence of AF is expected to increase …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Epidemiologic
studies suggest that the number of patients with AF will triple in the next 30 years, and …

Opinion statement Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and a major
cause of morbidity. In the past decade, there have been significant advances in the …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and affects over 33
million people worldwide. AF is associated with stroke and systemic thromboembolism …

The management of atrial fibrillation (AF) is plagued by, among other things, limitations in
the efficacy, tolerance, and safety of currently available agents for the conversion of AF to …

Atrial fibrillation is the most common cardiac arrhythmia and is a major cause of
cardiovascular morbidity and mortality in the Western world. Present pharmacological …